share_log

礼来在印度推出减肥药Mounjaro 击败诺和诺德占领主要市场

Eli Lilly and Co launched the weight loss drug Mounjaro in India, defeating Novo-Nordisk A/S to capture the major market.

Breakings ·  Mar 22 00:12

Eli Lilly and Co launched the diabetes and weight loss drug Mounjaro in India on Thursday, defeating competitor Novo-Nordisk A/S, entering the world's most populous country, India, which is currently struggling to address the rising rates of obesity and diabetes within its population. The innovative weight loss medications from Eli Lilly and Co in the USA and Novo-Nordisk A/S in Denmark are experiencing a surge in global demand, and investor interest has also driven up the pharmaceutical companies' valuations.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 226

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.